Marimed (MRMD) Accumulated Expenses (2012 - 2026)

Marimed (MRMD) has reported Accumulated Expenses for 14 consecutive years, with $10.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 34.54% year-over-year to $10.0 million in Q2 2026; TTM through Jun 2026 was $10.0 million, a 34.54% increase from a year earlier, with the FY2025 full-year figure at $9.5 million, up 114.41% from the prior year.
• Accumulated Expenses was $10.0 million for Q2 2026 at Marimed, down from $10.4 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $10.4 million in Q1 2026 and troughed at $1.7 million in Q1 2022.
• A 5-year average of $5.6 million and a median of $4.8 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses plunged 70.57% in 2022 and soared 114.41% in 2025, its largest moves.
• Over 5 years, Accumulated Expenses stood at $3.1 million in 2022, then gained by 14.82% to $3.5 million in 2023, then climbed by 24.96% to $4.4 million in 2024, then soared by 114.41% to $9.5 million in 2025, then increased by 4.87% to $10.0 million in 2026.
• The last three Accumulated Expenses figures came in at $10.0 million (Q2 2026), $10.4 million (Q1 2026), and $9.5 million (Q4 2025), per Business Quant data.